0001209191-23-053000.txt : 20231017 0001209191-23-053000.hdr.sgml : 20231017 20231017183856 ACCESSION NUMBER: 0001209191-23-053000 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231016 FILED AS OF DATE: 20231017 DATE AS OF CHANGE: 20231017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Campisi Peter Joseph Jr. CENTRAL INDEX KEY: 0001979458 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41747 FILM NUMBER: 231330582 MAIL ADDRESS: STREET 1: C/O TURNSTONE BIOLOGICS CORP. STREET 2: 9310 ATHENA CIRCLE, SUITE 300 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Turnstone Biologics Corp. CENTRAL INDEX KEY: 0001764974 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 832909368 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 920 BROADWAY STREET 2: 16TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 347-897-5988 MAIL ADDRESS: STREET 1: 920 BROADWAY STREET 2: 16TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-10-16 0 0001764974 Turnstone Biologics Corp. TSBX 0001979458 Campisi Peter Joseph Jr. C/O TURNSTONE BIOLOGICS CORP. 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037 0 1 0 0 Chief Legal Officer 0 Employee Stock Option (Right to Buy) 2.61 2023-10-16 4 A 0 44377 0.00 A 2033-10-15 Common Stock 44377 44377 D One fourth (1/4th) of the shares subject to the option award shall vest on October 12, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. /s/ P. Joseph Campisi, Jr. 2023-10-17